studiocasper-1
studiocasper-1 / iStockphoto.com
12 September 2017Americas

Janssen sues Aurobindo over ANDA

Janssen, a subsidiary of Johnson & Johnson, has sued generics company Aurobindo over the filing of an Abbreviated New Drug Application (ANDA).

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
15 November 2017   Janssen, a subsidiary of Johnson & Johnson, has dropped a lawsuit against Samsung's biopharmaceutical arm Samsung Bioepis.

More on this story

Americas
15 November 2017   Janssen, a subsidiary of Johnson & Johnson, has dropped a lawsuit against Samsung's biopharmaceutical arm Samsung Bioepis.

More on this story

Americas
15 November 2017   Janssen, a subsidiary of Johnson & Johnson, has dropped a lawsuit against Samsung's biopharmaceutical arm Samsung Bioepis.